Adverum Biotechnologies
ADVM
ADVM was delisted on the 8th of December, 2025.
76 hedge funds and large institutions have $62.3M invested in Adverum Biotechnologies in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 12 closing their positions.
25% more capital invested
Capital invested by funds: $49.8M → $62.3M (+$12.5M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
8% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 24
1% less funds holding
Funds holding: 77 → 76 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $37K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.59M |
| 2 |
Renaissance Technologies
New York
|
+$1.02M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$763K |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
+$411K |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$344K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.74M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.43M |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$589K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$567K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$444K |
ADVM Hedge Fund Activity: Q3 2016 in Review
76 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q3 2016, worth a combined $62.3M — up 25% from $49.8M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ADVM and 11 opened new positions — a net loss of 1 holder — while 24 trimmed existing stakes and 22 added.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $3.59M. The largest seller was Great Point Partners, exiting entirely with an estimated $1.74M sold.
- 76 institutional investors held Adverum Biotechnologies (ADVM) as of Q3 2016, down from 77 in Q2 2016.
- Funds reported $62.3M of Adverum Biotechnologies stock for Q3 2016, up 25% quarter-over-quarter.
- 11 funds opened new Adverum Biotechnologies positions in Q3 2016 and 12 closed out, a net change of -1 holder.
- The largest Adverum Biotechnologies buyer in Q3 2016 was EcoR1 Capital, an estimated $3.59M added.
- The largest Adverum Biotechnologies seller in Q3 2016 was Great Point Partners, an estimated $1.74M sold.
Based on aggregated 13F filings for Q3 2016.